SEC 13F Intelligence

Venbio Partners LLC / LYEL

Venbio Partners LLC’s Lyell Immunopharma Inc Position

Does Venbio Partners LLC own Lyell Immunopharma Inc (LYEL)? Yes — 337.7K shares worth $7M (+2.41% of its 13F portfolio) as of Q1 2026.

Position Value
$7M
Q1 2026
Shares
337.7K
% of Portfolio
+2.41%
Quarters Held
4
currently held

Position History LYEL

Reported value by quarter
Q2 ’25: $4MQ2 ’25Q3 ’25: $8MQ3 ’25Q4 ’25: $10MQ4 ’25Q1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026337.7K$7M+2.41%
Q4 2025337.7K$10M+4.81%
Q3 2025473.5K$8M+4.36%
Q2 2025473.5K$4M+3.65%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venbio Partners LLC’s full portfolio or all institutional holders of LYEL.